chrisvoncsefalvay/vaers-outcomes huggingface dataset:
C/o shortness of breath and feeling hot momentarily after receiving the covid vaccination.  States throat itchy but transient.  Educated regarding anaphylactic reactions  and airway closing.   States that it was only for a minute or two that she felt something.  Encouraged to wait 45 to 60 minutes to insure that she will not have further sxs.  VSS:  132/70-t8 pulse and regular, 98% oximeter reading
Two days after my vaccination a rash appeared on top of my hands. It started to spread to both of my hands, and then it went all the way to the top of my arm. It was many small bumps that looked like ant bites. They were very itchy. I took Allegra and some allergy pills. I put on topical ointment hydrocortisone. The rash lasted about two weeks.
Dry cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Dry cough) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 28-Apr-2021, the patient experienced COUGH (Dry cough). At the time of the report, COUGH (Dry cough) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment information was not provided by reporter.   This case was linked to MOD21-084979, MOD21-085082, MOD21-085067 (E2B Linked Report).; Sender's Comments:  MOD21-084979:cross linked id MOD21-085082:cross linked id MOD21-085067:cross linked id
Booster given 2 months early.  No symptoms present at the time of administration. Pt will wait to determine if symptoms present. If symptoms present themselves, pt will immediately seek medical assistance from medical professionals.
This spontaneous report was received from a physician, via company representatives and from a support services director, concerning to a patient of unknown age and gender. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On 25-FEB-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 10 single Ds 0.5 ml VIs 10 SDV (lot number and expiration date: K007262 and 25-NOV-2015 respectively; route of administration was not provided). The vaccine had an excursion of 32 degrees Fahrenheit (0 degrees Celsius) (lowest recorded temperature) for 304 hours (sum of hours in excursion). The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
About 1 hour after administration patient experienced hives, itching wide spread, and swelling of her lips
Pinched nerve in neck and numbness in right hand and arm and spasms in my back. I had my second epidural this afternoon. I have been having these since the end of July. I went and saw two chiropractors and then I went to see my doctor and put me on 11 different meds, none of that worked and nor did the physical therapy. I had 3 sessions but stopped because they weren't helping, and finally they decided to give me an epidural and that is helping. They added Gabapentin and that was helping with the spasms in my back. My right hand is to a point that I don't use it very often because it's not strong enough. Still experiencing these symptoms. Immediately after the vaccine was given, I did not have any symptoms. Had one ER visit, through this reaction to one of the medicines they had given me; they had given me three prescriptions at once and my lip swelled up. By the time I got there the swelling had gone down. No treatment.
Employee started having a red swollen very itchy L Deltoid that advanced to difficulty swallowing a couple of hours later. She was sent to the ER for allergic reaction. By the time she went to the ER her throat was red and swollen she was treated for anaphylaxis reaction.
Tested positive for Covid-19 on 7-19-2021. Hospitalized on 7-27-2021. Spent time in ICU. Release date unknown. Unable to contact case again for follow up questions.
Tachycardia, orthostatic intolerance, Autonomic dysfunction, overactive bladder, Postural Orthostatic Tachycardia Syndrome, presyncope upon standing. Signs of tachycardia and presyncope upon standing started about a week after receiving second dose. Symptoms were intermittent at first and seemed worse around menses.  Symptoms began to be persistent everyday after contracting a breakthrough case of Covid-19 on August 27, 2021. Currently being treated with Propanolol 10mg BID and lifestyle changes.
It began yesterday at 3:30. I came home from having the TD shot and  had a massive headache. It went from that to left arm feeling tingly. A few hours later my head still hurts right shoulder started hurting. When I went to bed I experienced nausea, back pain, flushing. My left arm felt oddly sick as it felt the shots contents surging thru it for hours. It felt sick... and then my left leg felt ill too, oddly like flu but only on left side of my body. Felt swollen and odd, but it really didnt look swollen. I tried to sleep but couldn't due to feeling ill. And the pain. Today it went up to face tingly, left side only, eye tingly and continued arm. Leg seems ok. Headache still present.
Mom called the Health Department stating that the child was complaining of his legs and arms hurting. He also said he felt dizzy. This was about 2 hours after the vaccine had been given. The mother took the child to the Pediatrician. Child was diagnosed with an ear and sinus infection. The pt. was placed on an antibiotic and breathing treatment per mom. Mom states she did not know that the pt. was sick or she would not of had him vaccinated.
May 11, 2021 SOB began at am upon waking. May 13th doctor was contacted and a chest x-ray and blood draw was obtained.  Results of the D-dimer were elevated and  the doctor ordered a CT scan for the morning of May 14th, 1 hour later doctor called and wanted patient to go to ER as a large blood clot was noted on the CT in the pulmonary artery. Patient went to ER and started IV Heparin and was sent to Hospital for admit over night  there obtained and ECHO and more blood work which was inconclusive in determining why she got the clot.
1st dose March 22 2021 and 2nd dose Jun 6 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose March 22 2021 and 2nd dose Jun 6 2021) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 035l40a and 040m31a) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose March 22 2021 and 2nd dose Jun 6 2021). On 06-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose March 22 2021 and 2nd dose Jun 6 2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided No treatment received by the patient
Nausea and vomiting and dizziness and fall and bleeding from brain, loss of appetite and loss of smell and headache and pain. Injury fracture of brain due to fall and chills and severe weakness and fall and fracture of brain (head).
Information regarding Flumist (2003-2004 Formula) (influenza virus vaccine, live intranasal (2003-2004 Formula) (influenza virus vaccine, live intranasal (2003-2004 formula) nasal solution (frozen) was received from a mother (a nurse) regarding her 20-year-old son who felt sick immediately following Flumist and later developed a fever. At 20 years of age, the patient received a dose the week of 08-Dec-2003. Medical History: The patient had a slight cold and little runny nose before receiving Flumist. Product Details: Indication for Flumist (2003-2004) was immunization. Product was administered the week of 08-Dec-2003 at health center. Dose regimen was 1 dose (intranasal). Concomitant Therapy: Patient was not taking concomitant therapy. Event Details: the patient "felt sick" immediately following Flumist administration. On 20-Dec-2003, he reported "feeling terrible", developing a fever of 102.6, which increased to 104.4 on the night of 21-Dec-2003. He was treated with Tylenol (acetaminophen) and Advil (ibuprofen), but the fever continued to rise. On the evening of 21-Dec-2003, he was taken to the emergency room at the hospital. He was prescribed Avelox (moxifloxacin) for a possible bacterial infection, and sent home. As of 23-Dec-2003, he was beginning to feel better. Test results: On 21-Dec-2003, chest x-ray results were negative for pneumonia. No additional information was available at the time of this report.
This spontaneous case reported by a consumer, describes the occurrence of somnolence (sleepy) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history provided. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced somnolence (sleepy). At the time of the report, somnolence (sleepy): resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. This case linked to MOD-2021-020448; MOD-2021-020371 (E2B linked report). Sender's comments: MOD-2021-020448: Same reporter, reporter herself. MOD-2021-020371: Same reporter, reporter's sister.
Client reported that about 5 hours after receiving the second dose of Pfizer COVID vaccine, she developed small welts on the right side of her forehead. The client stated the symptoms lasted about 4 hours. The client denied any other symptoms. The client placed an ice pack over the welts. The client's daughter called a nurse's line and was advised to place an ice pack over the welt and when to seek medical care. The client reported a history of hypertension and hypothyroidism controlled with medication.
Re-emergence of PHN/suspected vaccination failure; Re-emergence of PHN; burning sensation on his back; No longer experienced post-herpetic neuralgia; This serious case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had shingles around 2010). Previously administered products included Acyclovir (had PHN 8 years before receiving the first dose of the Shingrix vaccine). Concurrent medical conditions included benign prostatic hypertrophy. Concomitant products included tamsulosin.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix and Shingrix, the patient experienced vaccination failure (Verbatim: Re-emergence of PHN/suspected vaccination failure) (serious criteria GSK medically significant), post herpetic neuralgia (Verbatim: Re-emergence of PHN), burning sensation (Verbatim: burning sensation on his back) and unexpected therapeutic effect (Verbatim: No longer experienced post-herpetic neuralgia). The patient was treated with aciclovir (Acyclovir). The outcome of the vaccination failure and unexpected therapeutic effect were unknown and the outcome of the post herpetic neuralgia was not resolved and the outcome of the burning sensation was not reported.   It was unknown if the reporter considered the vaccination failure, post herpetic neuralgia and burning sensation to be related to Shingrix and Shingrix.  It was unknown if the company considered the vaccination failure, post herpetic neuralgia and burning sensation to be related to Shingrix and Shingrix.   Additional Information: GSK Receipt Date: 26-JUL-2023 The reporter was the patient. The patient stated that he received the full vaccination with Shingrix in 2018.  The day after receiving the first dose of Shingrix, the patient no longer experienced post-herpetic neuralgia. The patient stopped taking Acyclovir (which was prescribed for his PHN) once the PHN resolved.  The patient now reported that he was experiencing PHN again in his back.  The patient had restarted taking Acyclovir. He had no rash but just a burning sensation on his back. The reporter consented to follow up. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming post herpetic neuralgia were unknown at the time of reporting.
pt recvd vax 16FEB93 fever 104-105 oral; started that evening was given APAP & was nauseated & vomitted 17FEB93 w/t105; no local rxn @ site of inject;
On 5/13 I woke up with a sore throat which persisted until the next day.  By that evening, I had a fever, chills, and coughing. I went to a Clinic on 5/15 where they tested me for Covid, Influenza A and B and all were negative. So they stated that it was some type of virus and advised that I wait it out. It's been around a week and I feel much better with the exception of a cough that lingers.
Positive Hepatitis B Surface Antigen 1 hour After Injection; Initial Report Received on 13-Jun-2019  A pharmacist reported that patient EH, a 41-year-old male (race not provided) was administered with HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization and tested positive for hepatitis B surface antigen 1 hour after the injection.   The pharmacist was not aware of the patient's medical history.  Concomitant medications were not provided.    On 16-May-2019, the patient received a dose of HEPLISAV-B from a pre-filled syringe in the right deltoid (Lot # E9G4E, expiration date: 29-Dec-2021, NDC # unknown). The patient also received a hepatitis A vaccine in the left arm on the same date.    The patient tested positive for the hepatitis B surface antigen 1 hour later. The pharmacist stated that it was possible that the patient was hepatitis B positive before getting the injection. No further information was provided.   At the time of the report, the outcome of the event was not reported.  The reporter did not provide a seriousness assessment for the event.   Company comment: The company assessed the event of hepatitis B surface antigen positive as non-serious. The event of hepatitis B surface antigen positive is listed per HEPLISAV-B USPI.; Sender's Comments: The company assessed the event of hepatitis B surface antigen positive as non-serious. The event of hepatitis B surface antigen positive is listed per HEPLISAV-B USPI.
Lyme vaccine received on 10/2/00 and the following day, pt reports she had a fever to 104F and muscle aches for 3 days.
broke out in shingles; very debilitating nerve pain; eye sight is not good.; pain/depressed of being in chronic pain; small patch in the back; extreme fatigue; brain fog; hard time concentrating on things; depressed of being in chronic pain; got very very ill; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got very very ill), HERPES ZOSTER (broke out in shingles), FEELING ABNORMAL (brain fog), DISTURBANCE IN ATTENTION (hard time concentrating on things) and DEPRESSION (depressed of being in chronic pain) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sulfonamide allergy (Hives reaction), Penicillin allergy (Hives reaction), GERD since 2008 and Blood pressure high since 2015. Concomitant products included LISINOPRIL from 2015 to an unknown date, DEXLANSOPRAZOLE (DEXILANT) from 06-Jan-2008 to an unknown date, LEVOTHYROXINE SODIUM (SYNTHROID) from 2010 to an unknown date and HYDROCHLOORTHIAZIDE for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced FEELING ABNORMAL (brain fog), DISTURBANCE IN ATTENTION (hard time concentrating on things), DEPRESSION (depressed of being in chronic pain) and FATIGUE (extreme fatigue). On an unknown date, the patient experienced ILLNESS (got very very ill), HERPES ZOSTER (broke out in shingles), NEURALGIA (very debilitating nerve pain), VISION BLURRED (eye sight is not good.), PAIN (pain/depressed of being in chronic pain) and RASH (small patch in the back). The patient was treated with GABAPENTIN for Shingles, at a dose of 1 dosage form. At the time of the report, ILLNESS (got very very ill) had resolved, HERPES ZOSTER (broke out in shingles), PAIN (pain/depressed of being in chronic pain) and FATIGUE (extreme fatigue) had not resolved and FEELING ABNORMAL (brain fog), DISTURBANCE IN ATTENTION (hard time concentrating on things), DEPRESSION (depressed of being in chronic pain), NEURALGIA (very debilitating nerve pain), VISION BLURRED (eye sight is not good.) and RASH (small patch in the back) outcome was unknown.            Patient says she did dozens of medical tests to determine cause of nerve pain, but no reports provided.  She also took antivirals (18 days after starting shingles symptoms) to treat the symptoms.   This case was linked to MOD-2021-296653, MOD-2021-296286 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 31-Aug-2021: Follow-up received which includes patient height, weight, medical history and concomitant medications.
She threw up after having the injection. Called the Dr. He refused to acknowledge it, because it isn't a normal symptom.
I had a gall bladder attack and was flown to another State for removal.  It was removed on May 21 and I returned on May 27.  I do not believe this is at all related to the vaccination but when V Safe Called they insisted I fill out this form.
Patient reported having only the PCV13 previously, so it was recommended that she vaccinate with PNEUMOVAX 23. Later, we received notice that she'd already had the vaccine in June 2018. So this was the patient's 2nd PNEUMOVAX within 6 months.
Sore throat; Swollen throat; Stuffy head; Stuffy nose; Headache; Arm pain; Dizziness; Feeling of being dehydrated; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Apr2021 at 12:15 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 25Apr2021 at 14:00, the patient experienced sore throat, swollen throat, stuffy head, stuffy nose, headache, arm pain, dizziness and feeling of being dehydrated. The events did not result in doctor or other healthcare professional office/clinic visit/emergency visit. No therapeutic measures were taken as a result of events. Since the vaccination, the patient had been tested for COVID-19. On an unknown date, the patient underwent SARS-CoV-2 (nasal swab) and the result was negative. The clinical outcome of the events sore throat, swollen throat, stuffy head, stuffy nose, headache, arm pain, dizziness and feeling of being dehydrated was unknown at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Fever 1-2 days prior to fluid filled lesions trunk and extremities 6 days. Sister broke out 10/17/2005. Neither case was Dr confirmed. Out of school 10/27, 10/25, 10/31 and 11/01/2005.
friend were injected and were all poorly by the end of the day; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (friend were injected and were all poorly by the end of the day) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Dec-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Dec-2021, the patient experienced VACCINATION COMPLICATION (friend were injected and were all poorly by the end of the day). At the time of the report, VACCINATION COMPLICATION (friend were injected and were all poorly by the end of the day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient were injected on Sunday and was poorly by the end of the day. No concomitant medication were given. No treatment information were given.
something like flu; This is a spontaneous report from a contactable consumer(patient). A 79-year-old female patient received second dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot/batch number not provided), via an unspecified route of administration on an unspecified date(at the age of 79-years-old) as a single dose for COVID-19 immunization. The patient had received ibuprofen, via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) for an unspecified indication. The patient medical history and concomitant medications were not reported. She has received both doses of the Pfizer COVID-19 vaccine and experienced an AE that was something like flu. She took ibuprofen for that. Upon watching a program yesterday, she learned that aspirin would reduce the effectiveness of the vaccine. She would like to know more information on that. She had her second shot two weeks the day after tomorrow. Stated that she had a side effect of light flu. Stated that she was watching television and a call in said that if one takes Tylenol that it would not have effectiveness of vaccine. Stated that she took Ibuprofen and wanted to know would that cause a side effect of the vaccine or not. Is Pfizer COVID vaccine.The outcome of the events was unknown.  Information on the lot/batch number has been requested.  Follow-up (12May2021): Follow-up attempts completed. No further information expected.